BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 15, 2011
 |  BC Week In Review  |  Company News  |  Other News

Epigenomics genomics, diagnostic news

Epigenomics will restructure and reduce headcount by about 39 (46%) to 45 and will discontinue early stage research to focus on the U.S. market. Details on the cuts were not disclosed. Epigenomics said it is preparing for the U.S. launch of its second-generation colorectal cancer test ...

Read the full 214 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >